NCT00002526View on ClinicalTrials.gov

Chemotherapy in Treating Patients With Advanced Sarcoma

PHASE2CompletedINTERVENTIONAL
Enrollment

20

Participants

Timeline

Start Date

January 31, 1993

Primary Completion Date

September 30, 1995

Study Completion Date

September 30, 1995

Conditions
Ovarian CancerSarcoma
Interventions
BIOLOGICAL

filgrastim

DRUG

doxorubicin hydrochloride

DRUG

ifosfamide

Trial Locations (1)

CH-1011

Centre Hospitalier Universitaire Vaudois, Lausanne

All Listed Sponsors
lead

Swiss Cancer Institute

OTHER

NCT00002526 - Chemotherapy in Treating Patients With Advanced Sarcoma | Biotech Hunter | Biotech Hunter